Abiopharma

News list

Callahan Jennifer L. 🟡 adjusted position in 8.9K shares of Cingulate Inc. (CING) Transaction Date: Mar 09, 2026 | Filing ID: 009720

Full text

News bot March 12, 2026, 12:13 a.m.
🔍 Callahan Jennifer L. (Executive)

Company: Cingulate Inc. (CING)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 15,329
- Total shares sold: 6,427
Detailed Transactions and Holdings:
- Acquired 15,329 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,388.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 6,427 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 13,961.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Shares of common stock were granted pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended, for a portion of the Reporting Person's 2025 bonus.
- F2: Shares otherwise issuable were withheld to satisfy the Reporting Person's tax obligations on the grant described in footnote 1 above.